04:20 PM EDT, 03/23/2026 (MT Newswires) -- Abivax ( ABVX ) reported full-year 2025 net loss late Monday of 336.1 million euros ($390.4 million), widening from a loss of 176.2 million euros a year earlier.

As of Dec. 31, the company had cash and cash equivalents of 530.4 million euros, expected to fund operations into Q4 2027.

Sofinnova Partners, represented by Kinam Hong, stepped down from the board last week, the company added.